Long non-coding RNAs as modulators and therapeutic targets in non-alcoholic fatty liver disease (NAFLD)

Powell, 2021, Non-alcoholic fatty liver disease, Lancet Lond Engl, 397, 2212, 10.1016/S0140-6736(20)32511-3 Cotter, 2020, Nonalcoholic fatty liver disease 2020: the state of the disease, Gastroenterology, 158, 1851, 10.1053/j.gastro.2020.01.052 Genua, 2022, NAFLD and type 2 diabetes: a practical guide for the joint management, Gastroenterol Hepatol, 10.1016/j.gastrohep.2022.12.002 Younossi, 2019, The global epidemiology of NAFLD and NASH in patients with type 2 diabetes: a systematic review and meta-analysis, J Hepatol, 71, 793, 10.1016/j.jhep.2019.06.021 Polyzos, 2019, Obesity and nonalcoholic fatty liver disease: from pathophysiology to therapeutics, Metabolism, 92, 82, 10.1016/j.metabol.2018.11.014 Jonas, 2021, Genetic and epigenetic factors determining NAFLD risk, Mol Metab, 50, 101111, 10.1016/j.molmet.2020.101111 Yu, 2021, The contribution of dietary fructose to non-alcoholic fatty liver disease, Front Pharmacol, 12, 783393, 10.3389/fphar.2021.783393 Fang, 2018, Pathogenesis of non-alcoholic fatty liver disease in children and adolescence: from “two hit theory” to “multiple hit model”, World J Gastroenterol, 24, 2974, 10.3748/wjg.v24.i27.2974 Tilg, 2010, Evolution of inflammation in nonalcoholic fatty liver disease: the multiple parallel hits hypothesis, Hepatol Baltim Md, 52, 1836, 10.1002/hep.24001 Zou, 2020, Understanding the role of exercise in nonalcoholic fatty liver disease: ERS-linked molecular pathways, Mediators Inflamm, 2020, 6412916, 10.1155/2020/6412916 Zhang, 2022, LncRNA-mediated adipogenesis in different adipocytes, Int J Mol Sci, 23, 7488, 10.3390/ijms23137488 Schmidt, 2020, Targeting the oncogenic long non-coding RNA SLNCR1 by blocking its sequence-specific binding to the androgen receptor, Cell Rep, 30, 541, 10.1016/j.celrep.2019.12.011 Zhang, 2021, lncRNA DANCR promotes the migration an invasion and of trophoblast cells through microRNA-214-5p in preeclampsia, Bioengineered, 12, 9424, 10.1080/21655979.2021.1988373 Okabe, 2022, G0S2 regulates innate immunity in Kawasaki disease via lncRNA HSD11B1-AS1, Pediatr Res, 92, 378, 10.1038/s41390-022-01999-9 Sun, 2015, Genome-wide analysis of long noncoding RNA expression profiles in patients with non-alcoholic fatty liver disease, IUBMB Life, 67, 847, 10.1002/iub.1442 Guo, 2018, Ultraconserved element uc.372 drives hepatic lipid accumulation by suppressing miR-195/miR4668 maturation, Nat Commun, 9, 612, 10.1038/s41467-018-03072-8 Chen, 2019, LncRNA NEAT1 promotes hepatic lipid accumulation via regulating miR-146a-5p/ROCK1 in nonalcoholic fatty liver disease, Life Sci, 235, 116829, 10.1016/j.lfs.2019.116829 Sun, 2019, LncRNA NEAT1-MicroRNA-140 axis exacerbates nonalcoholic fatty liver through interrupting AMPK/SREBP-1 signaling, Biochem Biophys Res Commun, 516, 584, 10.1016/j.bbrc.2019.06.104 Xiang, 2022, LncRNA MALAT1 promotes PPARα/CD36-mediated hepatic lipogenesis in nonalcoholic fatty liver disease by modulating miR-206/ARNT axis, Front Bioeng Biotechnol, 10, 858558, 10.3389/fbioe.2022.858558 Liu, 2019, LncRNA-H19 promotes hepatic lipogenesis by directly regulating miR-130a/PPARγ axis in non-alcoholic fatty liver disease, Biosci Rep, 39 Guo, 2022, LncRNA HOTAIR regulates the lipid accumulation in non-alcoholic fatty liver disease via miR-130b-3p/ROCK1 axis, Cell Signal, 90, 110190, 10.1016/j.cellsig.2021.110190 Chen, 2021, Long non-coding RNA AC012668 suppresses non-alcoholic fatty liver disease by competing for microRNA miR-380-5p with lipoprotein-related protein LRP2, Bioengineered, 12, 6738, 10.1080/21655979.2021.1960463 Chu, 2022, LncNONMMUG027912 alleviates lipid accumulation through AMPKα/mTOR/SREBP1C axis in nonalcoholic fatty liver, Biochem Biophys Res Commun, 618, 8, 10.1016/j.bbrc.2022.06.029 Huang, 2019, LncRNA MEG3 functions as a ceRNA in regulating hepatic lipogenesis by competitively binding to miR-21 with LRP6, Metabolism, 94, 1, 10.1016/j.metabol.2019.01.018 Liu, 2014, SRA regulates adipogenesis by modulating p38/JNK phosphorylation and stimulating insulin receptor gene expression and downstream signaling, PLOS ONE, 9, e95416, 10.1371/journal.pone.0095416 Hu, 2022, Acetylation of H3K27 activated lncRNA NEAT1 and promoted hepatic lipid accumulation in non-alcoholic fatty liver disease via regulating miR-212-5p/GRIA3, Mol Cell Biochem, 477, 191, 10.1007/s11010-021-04269-0 Zou, 2022, LncRNA MEG3 up-regulates SIRT6 by ubiquitinating EZH2 and alleviates nonalcoholic fatty liver disease, Cell Death Discov, 8, 103, 10.1038/s41420-022-00889-7 Qin, 2016, A long non-coding RNA, APOA4-AS, regulates APOA4 expression depending on HuR in mice, Nucleic Acids Res, 44, 6423, 10.1093/nar/gkw341 Wang, 2022, RNA binding protein HuR protects against NAFLD by suppressing long noncoding RNA H19 expression, Cell Biosci, 12, 172, 10.1186/s13578-022-00910-7 Tang, 2020, The long noncoding RNA Blnc1 protects against diet-induced obesity by promoting mitochondrial function in white fat, Diabetes Metab Syndr Obes Targets Ther, 13, 1189, 10.2147/DMSO.S248692 Shen, 2022, Long noncoding RNA lncRHL regulates hepatic VLDL secretion by modulating hnRNPU/BMAL1/MTTP axis, Diabetes, 71, 1915, 10.2337/db21-1145 Chi, 2020, Long noncoding RNA lncARSR promotes nonalcoholic fatty liver disease and hepatocellular carcinoma by promoting YAP1 and activating the IRS2/AKT pathway, J Transl Med, 18, 126, 10.1186/s12967-020-02225-y Wang, 2020, Long non-coding RNA (lncRNA) H19 induces hepatic steatosis through activating MLXIPL and mTORC1 networks in hepatocytes, J Cell Mol Med, 24, 1399, 10.1111/jcmm.14818 Zhang, 2018, Long noncoding RNA lncARSR promotes hepatic lipogenesis via Akt/SREBP-1c pathway and contributes to the pathogenesis of nonalcoholic steatohepatitis, Biochem Biophys Res Commun, 499, 66, 10.1016/j.bbrc.2018.03.127 Chen, 2016, LncRNA SRA promotes hepatic steatosis through repressing the expression of adipose triglyceride lipase (ATGL), Sci Rep, 6, 35531, 10.1038/srep35531 Jin, 2019, lncRNA NEAT1 regulates fibrosis and inflammatory response induced by nonalcoholic fatty liver by regulating miR-506/GLI3, Eur Cytokine Netw, 30, 98, 10.1684/ecn.2019.0432 Lin, 2021, Oscillating lncRNA Platr4 regulates NLRP3 inflammasome to ameliorate nonalcoholic steatohepatitis in mice, Theranostics, 11, 426, 10.7150/thno.50281 Chen, 2019, Long noncoding RNA FLRL2 alleviated nonalcoholic fatty liver disease through Arntl-Sirt1 pathway, FASEB J Off Publ Fed Am Soc Exp Biol, 33, 11411 Ye, 2021, LncRNA-Gm9795 promotes inflammation in non-alcoholic steatohepatitis via NF-[Formula: see text]B/JNK pathway by endoplasmic reticulum stress, J Transl Med, 19, 101, 10.1186/s12967-021-02769-7 Dong, 2019, lncRNA GAS5 restrains CCl4-induced hepatic fibrosis by targeting miR-23a through the PTEN/PI3K/Akt signaling pathway, Am J Physiol Gastrointest Liver Physiol, 316, G539, 10.1152/ajpgi.00249.2018 Han, 2020, Expression of the long noncoding RNA GAS5 correlates with liver fibrosis in patients with nonalcoholic fatty liver disease, Genes, 11, 545, 10.3390/genes11050545 Yu, 2017, HOTAIR epigenetically modulates PTEN expression via microRNA-29b: a novel mechanism in regulation of liver fibrosis, Mol Ther, 25, 205, 10.1016/j.ymthe.2016.10.015 Yu, 2015, MALAT1 functions as a competing endogenous RNA to mediate Rac1 expression by sequestering miR-101b in liver fibrosis, Cell Cycle Georget Tex, 14, 3885, 10.1080/15384101.2015.1120917 Wu, 2021, LncRNA MEG3 reverses CCl4-induced liver fibrosis by targeting NLRC5, Eur J Pharmacol, 911, 174462, 10.1016/j.ejphar.2021.174462 Zhang, 2017, The liver-enriched lnc-LFAR1 promotes liver fibrosis by activating TGFβ and Notch pathways, Nat Commun, 8, 144, 10.1038/s41467-017-00204-4 Wu, 2019, linc-SCRG1 accelerates liver fibrosis by decreasing RNA-binding protein tristetraprolin, FASEB J Off Publ Fed Am Soc Exp Biol, 33, 2105 Wang, 2022, LINC01468 drives NAFLD-HCC progression through CUL4A-linked degradation of SHIP2, Cell Death Discov, 8, 449, 10.1038/s41420-022-01234-8 Liu, 2022, Long non-coding RNA SNHG6 couples cholesterol sensing with mTORC1 activation in hepatocellular carcinoma, Nat Metab, 4, 1022, 10.1038/s42255-022-00616-7 Wang, 2019, Silencing of lncRNA SNHG20 delays the progression of nonalcoholic fatty liver disease to hepatocellular carcinoma via regulating liver Kupffer cells polarization, IUBMB Life, 71, 1952, 10.1002/iub.2137 Yang, 2014, LncRNA: a link between RNA and cancer, Biochim Biophys Acta, 1839, 1097, 10.1016/j.bbagrm.2014.08.012 Documento de consenso. Manejo de la enfermedad hepática grasa no alcohólica (EHGNA). Guía de práctica clínica. Gastroenterol Hepatol. 2018; 41: 328–49. Wu, 2022, Aerobic exercise promotes the expression of ATGL and attenuates inflammation to improve hepatic steatosis via lncRNA SRA, Sci Rep, 12, 5370, 10.1038/s41598-022-09174-0 Di Mauro, 2021, Coffee restores expression of lncRNAs involved in steatosis and fibrosis in a mouse model of NAFLD, Nutrients, 13, 2952, 10.3390/nu13092952 Zhang, 2013, Berberine potently attenuates intestinal polyps growth in ApcMin mice and familial adenomatous polyposis patients through inhibition of Wnt signalling, J Cell Mol Med, 17, 1484, 10.1111/jcmm.12119 Yuan, 2015, Berberine ameliorates nonalcoholic fatty liver disease by a global modulation of hepatic mRNA and lncRNA expression profiles, J Transl Med, 13, 24, 10.1186/s12967-015-0383-6 Gadallah, 2021, Probiotic–prebiotic–synbiotic modulation of (YAP1, LATS1 and NF2 mRNAs/miR-1205/lncRNA SRD5A3-AS1) panel in NASH animal model, Biomed Pharmacother, 140, 111781, 10.1016/j.biopha.2021.111781 Xue, 2022, Long non-coding RNA LINC00680 functions as a ceRNA to promote esophageal squamous cell carcinoma progression through the miR-423-5p/PAK6 axis, Mol Cancer, 21, 69, 10.1186/s12943-022-01539-3 Zhou, 2022, Chitosan-gelatin-EGCG nanoparticle-meditated LncRNA TMEM44-AS1 silencing to activate the P53 signaling pathway for the synergistic reversal of 5-FU resistance in gastric cancer, Adv Sci Weinh Baden-Wurtt Ger, 9, e2105077